An experimental gene-editing treatment shows promise for permanently lowering levels of cholesterol and triglycerides, ...
People who have tried medication to lower their dangerously high levels of cholesterol and other blood fats – without success ...
In a phase 1 trial, a gene-editing therapy that targets ANGPTL3 was associated with few serious adverse events and at higher ...
The approach is “very exciting,” but one expert says a lot more research is needed, especially around safety, before clinical ...
Pioneering CRISPR trial shows single infusion permanently lowers bad cholesterol by 50% in patients who don't respond to medication.
Dangerously high levels of “bad” cholesterol and triglycerides may be reduced by gene editing, in what study researchers hope will be a “one and done” treatment.
The Brighterside of News on MSN

Bowhead whales may hold key to humans living for centuries

A body that weighs as much as a small airplane should face steep odds against cancer. You may expect that from a creature ...
Chinechendo Eze is a Nigerian microbiologist and biotechnologist with research focuses on how to genetically engineer crops to enhance growth and resilience. She is a doctoral student and a graduate ...
Over 60% of human infectious diseases come from animals. Learn what zoonotic diseases are, how they are transmitted, and why ...
If you missed the previous crypto bull run, this could be your chance. With BexBack's 100x leverage and 100% deposit bonus and $100 bonus for new users, Deposit more than 0.01 BTC or 1000 USDT and ...
The breakthrough did not come until 1953, when Watson visited Wilkins at King’s College in London, and Wilkins showed him a ...